Best Peptides for Muscle Growth

By R2 Medical Clinic — Denver, CO

Not all peptide clinics offer the same compounds. R2 Medical in Denver prescribes a specific set of peptides backed by clinical evidence, sourced from licensed compounding pharmacies, and matched to each patient's lab results. This guide covers the five peptides R2 Medical uses most often for patients focused on building lean muscle and improving body composition.

Important: The peptides discussed here are not FDA-approved for muscle growth or athletic performance in healthy adults. They are available through compounding pharmacies for off-label use. Clinical evidence supporting these uses in healthy adults remains limited. R2 Medical evaluates each patient individually before prescribing and does not prescribe peptides without a full lab review.

1. Ipamorelin

Ipamorelin is a selective growth hormone releasing peptide (GHRP) and R2 Medical's primary injectable option for patients targeting lean mass and body recomposition. What sets it apart from older GHRPs is its selectivity — it produces a strong GH pulse without significantly elevating cortisol or prolactin, which made compounds like GHRP-6 problematic for extended use.

A study published in European Journal of Endocrinology confirmed Ipamorelin produced equivalent GH release to GHRP-6 in comparative models while showing negligible impact on ACTH and cortisol — the stress hormones that drive fat storage and muscle breakdown when chronically elevated (PMID 10368185).

In practice, patients on Ipamorelin at R2 Medical report improved sleep depth within the first 2–3 weeks, followed by gradual improvements in lean mass and recovery over 3–6 months. It is administered via subcutaneous injection, typically timed 30–60 minutes before sleep to align with the body's natural nocturnal GH pulse.

Common side effects at standard doses are mild: brief flushing post-injection, occasional water retention early in treatment, and transient tingling in the extremities. These typically resolve within the first few weeks. See the full protocol overview at R2's peptide therapy page.

2. Sermorelin

Sermorelin is a 29-amino-acid synthetic fragment of growth hormone-releasing hormone (GHRH) and has the longest clinical track record of any GH-stimulating peptide in use today. It was originally developed as a diagnostic agent for GH deficiency in children, which means it has more published human safety data than most compounds in this space.

The key mechanism: Sermorelin stimulates the pituitary to produce its own GH rather than supplying GH directly. Because the pituitary's feedback loop stays intact, GH cannot be driven to supraphysiologic levels — a meaningful safety advantage over direct HGH injections. Research published in Journal of Clinical Endocrinology & Metabolism found Sermorelin increased IGF-1 and lean body mass in GH-deficient adults over a 6-month protocol with a clean safety profile (PMID 8365247).

R2 Medical uses Sermorelin as the first-line recommendation for patients new to GH-axis therapy — particularly those whose labs show mild GH decline rather than severe deficiency. Its shorter half-life means nightly dosing, but this closely mirrors the body's natural nocturnal GH release pattern.

Best for: Adults 35 and older who are new to peptide therapy and want a conservative, well-studied starting point. Hormone health evaluations at R2 include IGF-1 testing to determine whether Sermorelin is the right fit or whether a more aggressive protocol is warranted.

3. Tesamorelin

Tesamorelin is a stabilized analogue of GHRH and represents the most potent GH-stimulating peptide in R2 Medical's formulary. It is the only GHRH analogue with FDA approval — specifically for HIV-associated lipodystrophy — which means it has more rigorous human clinical data than most peptides in this category.

Tesamorelin's stabilized structure gives it a longer duration of action than Sermorelin, producing sustained GH and IGF-1 elevation. Studies in non-HIV populations have shown meaningful reductions in visceral fat alongside preservation of lean mass. Its primary application at R2 Medical is body recomposition in patients who need a more aggressive GH stimulus than Sermorelin provides — particularly those with significant visceral fat alongside low muscle mass.

It is administered subcutaneously and requires the same lab monitoring as other GH-stimulating peptides: baseline IGF-1, follow-up at 6–8 weeks, and ongoing metabolic panel review. Patients with active malignancy, pituitary disorders, or pregnancy are not candidates. R2 Medical reviews all relevant history before prescribing. More detail at the peptide therapy program page.

4. BPC-157

BPC-157 (Body Protection Compound 157) is not a GH secretagogue. Its role in a muscle-building protocol is indirect but significant: it keeps the body able to train and recover at high intensity by accelerating connective tissue repair and reducing the inflammation that accumulates with heavy training.

BPC-157 is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It upregulates growth hormone receptors in tendon fibroblasts, promotes new blood vessel formation in injured tissue, and exerts anti-inflammatory effects. Animal model studies show accelerated healing of tendon, ligament, and muscle injuries — human RCTs are limited but the safety profile at clinical doses is favorable (PMID 24481896).

At R2 Medical, BPC-157 is most often prescribed for:

Chronic tendon injuries at the shoulder, elbow, or knee limiting training
Soft-tissue recovery post-surgery alongside standard rehabilitation
High-volume athletes dealing with repetitive stress accumulation
Gut inflammation that may be worsened by high protein intake and training stress

R2's PRP therapy is frequently combined with BPC-157 for patients with acute injuries needing faster, targeted intervention at the injury site.

5. MK-677 (Ibutamoren)

MK-677, also known as Ibutamoren, is a GH secretagogue — not technically a peptide, but included in peptide therapy programs because it works through the same GH axis. Its defining feature is oral bioavailability: it survives the digestive tract intact and acts on ghrelin receptors in the pituitary to stimulate GH and IGF-1 production.

A 12-month randomized controlled trial published in Journal of Clinical Endocrinology & Metabolism found MK-677 at 25 mg/day increased IGF-1 by approximately 60% and produced significant increases in lean body mass alongside reductions in fat mass compared to placebo (PMID 9467542).

Tradeoffs worth knowing upfront: MK-677's ghrelin mimicry drives noticeable appetite increase, particularly in the first month. Initial water retention of 3–5 lbs is common and usually resolves by week 6. It also produces a modest, sustained elevation in fasting blood glucose that makes it inappropriate for patients with diabetes, pre-diabetes, or insulin resistance without close monitoring. R2 Medical requires a fasting glucose and HbA1c before prescribing.

MK-677 is best suited to patients who want an oral protocol, have needle aversion, or want to maintain a GH stimulus during periods between injectable cycles. The full comparison of injectable vs. oral options is covered in the oral peptides guide.

How R2 Medical Builds Your Protocol

R2 Medical does not recommend peptides based on symptoms alone. Every patient starts with a full lab panel: IGF-1, growth hormone markers, comprehensive metabolic panel, and a complete hormone profile. The peptide protocol — which compounds, what dose, and how long — is built around your actual numbers and health history, not a generic template.

The clinic serves patients from across Denver and the Front Range including Cherry Creek, Highlands Ranch, Arvada, Castle Rock, Wheat Ridge, Centennial, and Parker, at three locations:

Call (720) 640-2333 or visit the contact page to schedule. Same-week appointments are typically available.

Common Questions

How long until I see results?

Sleep quality and recovery improvements are usually noticeable within 2–4 weeks. Measurable lean mass changes typically appear at 8–12 weeks. The most significant body composition results come at the 4–6 month mark. These are long-term protocols — not quick fixes.

Can I use more than one peptide at the same time?

Yes. R2 Medical frequently combines protocols — Ipamorelin for GH stimulation alongside BPC-157 for recovery is a common combination for active patients. All combinations are reviewed and prescribed by a physician. Do not self-combine peptides without medical supervision.

Do peptides affect testosterone levels?

GH-stimulating peptides do not directly replace or suppress testosterone. However, men dealing with both low GH and low testosterone — a common combination in men over 40 — often benefit from addressing both at the same time. R2's men's hormone health program covers both.

Are these peptides safe long-term?

Long-term safety data in healthy adults is limited for most compounds in this category — that is an honest answer. Sermorelin has the most established track record. All other peptides at R2 are monitored with regular lab work to catch any adverse changes early. R2 Medical does not prescribe indefinitely without follow-up.